Jain M - Search Results

1

Pseudomonas aeruginosa and Children With Cystic Fibrosis.

Sala MA, Jain M. Sala MA, et al. Among authors: jain m. Clin Infect Dis. 2021 Nov 2;73(9):e2529-e2530. doi: 10.1093/cid/ciaa765. Clin Infect Dis. 2021. PMID: 32544945 No abstract available.

2

Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.

Jain M, Ramirez D, Seshadri R, Cullina JF, Powers CA, Schulert GS, Bar-Meir M, Sullivan CL, McColley SA, Hauser AR. Jain M, et al. J Clin Microbiol. 2004 Nov;42(11):5229-37. doi: 10.1128/JCM.42.11.5229-5237.2004. J Clin Microbiol. 2004. PMID: 15528719 Free PMC article.

3

Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection.

Jain M, Bar-Meir M, McColley S, Cullina J, Potter E, Powers C, Prickett M, Seshadri R, Jovanovic B, Petrocheilou A, King JD, Hauser AR. Jain M, et al. Transl Res. 2008 Dec;152(6):257-64. doi: 10.1016/j.trsl.2008.10.003. Epub 2008 Oct 31. Transl Res. 2008. PMID: 19059160 Free PMC article.

4

Clinical significance of microbial infection and adaptation in cystic fibrosis.

Hauser AR, Jain M, Bar-Meir M, McColley SA. Hauser AR, et al. Among authors: jain m. Clin Microbiol Rev. 2011 Jan;24(1):29-70. doi: 10.1128/CMR.00036-10. Clin Microbiol Rev. 2011. PMID: 21233507 Free PMC article. Review.

5

Gene therapy in cystic fibrosis.

Prickett M, Jain M. Prickett M, et al. Among authors: jain m. Transl Res. 2013 Apr;161(4):255-64. doi: 10.1016/j.trsl.2012.12.001. Epub 2012 Dec 26. Transl Res. 2013. PMID: 23273902 Review.

6

Update in cystic fibrosis 2013.

Jain M, Goss CH. Jain M, et al. Am J Respir Crit Care Med. 2014 May 15;189(10):1181-6. doi: 10.1164/rccm.201402-0203UP. Am J Respir Crit Care Med. 2014. PMID: 24832742 No abstract available.

7

Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.

Prickett MH, Hauser AR, McColley SA, Cullina J, Potter E, Powers C, Jain M. Prickett MH, et al. Among authors: jain m. Thorax. 2017 Jan;72(1):40-47. doi: 10.1136/thoraxjnl-2015-208027. Epub 2016 Jun 20. Thorax. 2017. PMID: 27325751 Free PMC article.

8

Antibiotic duration and changes in FEV₁ are not associated with time until next exacerbation in adult cystic fibrosis: a single center study.

Espel JC, Palac HL, Cullina JF, Clarke AP, McColley SA, Prickett MH, Jain M. Espel JC, et al. Among authors: jain m. BMC Pulm Med. 2017 Nov 29;17(1):160. doi: 10.1186/s12890-017-0503-6. BMC Pulm Med. 2017. PMID: 29187171 Free PMC article.

9

The relationship between sweat chloride levels and mortality in cystic fibrosis varies by individual genotype.

Espel JC, Palac HL, Bharat A, Cullina J, Prickett M, Sala M, McColley SA, Jain M. Espel JC, et al. Among authors: jain m. J Cyst Fibros. 2018 Jan;17(1):34-42. doi: 10.1016/j.jcf.2017.11.002. Epub 2017 Dec 6. J Cyst Fibros. 2018. PMID: 29221674 Free article.

10

Tezacaftor for the treatment of cystic fibrosis.

Sala MA, Jain M. Sala MA, et al. Among authors: jain m. Expert Rev Respir Med. 2018 Sep;12(9):725-732. doi: 10.1080/17476348.2018.1507741. Epub 2018 Aug 9. Expert Rev Respir Med. 2018. PMID: 30073878 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,421 results

Search Page

Filters